Sotera Health Announces First-Quarter 2025 Earnings Release Date
Rhea-AI Summary
Sotera Health (Nasdaq: SHC), a leading global provider of sterilization solutions and lab testing services for the healthcare industry, has scheduled its first-quarter 2025 financial results release for Thursday, May 1, 2025, before market opening.
The company will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss Q1 2025 results and operating highlights. Participants can join via phone (1-844-481-2916 US toll-free; 1-412-317-0709 international) or access the live webcast through the Investor Relations section of Sotera Health's website. Conference materials will be available, and a webcast replay will be accessible later that day.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, SHC declined 1.53%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial results and operating highlights.
To participate in the live call, please dial 1-844-481-2916 (toll-free in the United States), or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call will be accessible at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health, along with the accompanying materials. A replay of the webcast will be available on the Company’s website later in the day on May 1st.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
| Contacts | |
| Jason Peterson Vice President, Investor Relations & Treasurer IR@soterahealth.com | |
| Kristin Gibbs Chief Marketing Officer, Sotera Health kgibbs@soterahealth.com | |
Source: Sotera Health Company
FAQ
When will Sotera Health (SHC) release Q1 2025 earnings?
How can investors join Sotera Health's Q1 2025 earnings call?
Where can I find Sotera Health's (SHC) Q1 2025 earnings presentation materials?
Will there be a replay available for Sotera Health's Q1 2025 earnings call?
